The North America has emerged as a key hub for advanced respiratory diagnostics, driven by the increasing prevalence of chronic respiratory diseases and the adoption of non-effort dependent lung function testing methods. Oscillometry devices, including impulse oscillometry (IOS) and forced oscillation technique (FOT), measure airway resistance and reactance during normal breathing, making them particularly suitable for pediatric, elderly, and critically ill patients.

The Oscillometry Market North America is projected to grow steadily from US$168.30 Million in 2024 to US$242.66 Million by 2031, with a compound annual growth rate of 5.5% during 2025–2031. This growth is supported by advanced healthcare infrastructure, strong research and development initiatives, increasing awareness of respiratory conditions, and favorable reimbursement policies.

Key Growth Drivers in North America

Several factors are driving the adoption of oscillometry devices across North America:

• High Prevalence of Chronic Respiratory Diseases: Asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders are widespread, creating consistent demand for accurate, effort-independent diagnostics.
• Advanced Healthcare Infrastructure: State-of-the-art hospitals and diagnostic centers facilitate the integration of oscillometry systems into routine clinical practice.
• Research and Development Focus: Strong investment in pulmonary research promotes adoption of new technologies and hybrid devices.
• Home and Remote Patient Monitoring: Telehealth and remote monitoring solutions are increasingly implemented, allowing patients to track lung function without frequent hospital visits.

These factors make North America a leading region for oscillometry adoption and technology integration.

Segmentation by Product and Technology

Understanding regional product and technology adoption provides insights into market dynamics:

• By Product:
  • Devices: Central to clinical and research diagnostics, providing accurate measurement of airway resistance and reactance.
  • Accessories: Include filters, mouthpieces, nose clips, calibration syringes, and software modules that support device operation and data analysis.
• By Technology:
  • Impulse Oscillometry (IOS): Widely used in clinical settings for pediatric and adult patient testing.
  • Forced Oscillation Technique (FOT): Utilized primarily in research institutions for detailed pulmonary assessment.
  • Hybrid Devices: Integration of IOS and FOT with additional diagnostic features enhances versatility and clinical utility.

The region’s advanced healthcare infrastructure supports the adoption of both clinical and research-oriented oscillometry technologies.

Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00042188 

Applications and End Users in North America

Oscillometry systems are applied across various clinical indications and healthcare settings:

• Applications:
  • Asthma diagnosis and management
  • COPD monitoring and treatment optimization
  • Evaluation of other respiratory disorders
• End Users:
  • Hospitals
  • Diagnostic laboratories
  • Research institutions and specialty clinics

The diverse range of applications and end users ensures steady adoption across North America.

Key Players in North America

Several companies are actively shaping the North American oscillometry landscape through innovation, partnerships, and expansion:

• Morgan Scientific Inc
• Chest MI Inc
• MGC Diagnostics Corp
• Vitalograph Ltd
• COSMED Srl
• THORASYS Thoracic Medical Systems Inc
• Jaeger Medical GmbH
• Cognita Labs LLC
• IngMar Medical
• GANSHORN Medizin Electronic GmbH
• Lothar Medical GmbH

These players focus on developing advanced, portable, and hybrid devices while enhancing digital connectivity to support telehealth and remote patient monitoring initiatives.

Future Outlook

The North American oscillometry sector is expected to maintain steady growth, driven by technological innovation, digital health integration, and rising awareness of chronic respiratory conditions. The region’s advanced healthcare infrastructure, combined with supportive reimbursement policies and research-driven adoption, will continue to encourage clinicians to utilize oscillometry devices. Portable and hybrid systems are likely to see wider implementation across hospitals, diagnostic laboratories, and home-based monitoring programs. Additionally, telehealth and AI-powered analytics will further enhance patient management and early detection of respiratory diseases. Overall, North America is positioned to remain a leading region in the global oscillometry landscape, providing opportunities for manufacturers, healthcare providers, and research institutions to drive improved respiratory care outcomes.

Related Reports @ 

Bariatric Surgery Devices Market Growth, Size, Share, Trends, Key Players Analysis, and Forecast till 2031

Brachytherapy Devices Market Share, Size & Demand by 2034

About Us -

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Information -

Email: sales@theinsightpartners.com

Phone: +1-646-491-9876
Also Available in : Korean| German| Japanese| French| Chinese| Italian| Spanish